AMG-1
| Code | Size | Price |
|---|
| SYN-1143-M100 | 100 mg | Enquire |
Quantity:
| SYN-1143-M050 | 50 mg | Enquire |
Quantity:
| SYN-1143-M001 | 1 mg | £203.00 |
Quantity:
| SYN-1143-M005 | 5 mg | £332.00 |
Quantity:
| SYN-1143-M010 | 10 mg | £514.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
AMG1
Appearance:
Solid.
CAS:
913376-84-8
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS07
Hazards:
H303, H317, H333
InChi:
InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(21-8-6-5-7-9-21)35(19)18-31(2,3)39)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(40-4)11-12-23(25)26/h5-17,39H,18H2,1-4H3,(H,34,37)
InChiKey:
UYMSIPINLJNNOU-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 913376-84-8. Formula: C31H29FN4O5. MW: 556.6. AMG-1 is a potent inhibitor of human c-Met and RON with IC(50) values of 4 and 9nM respectively.
Molecular Formula:
C31H29FN4O5
Molecular Weight:
556.6
Package Type:
Plastic Vial
Precautions:
P261, P272, P280, P302, P352, P333, P313, P321, P363, P501
Product Description:
AMG-1 is a potent inhibitor of human c-Met and RON with IC(50) values of 4 and 9nM respectively.
Purity:
>95%
Signal word:
Warning
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
The adenosine analogue and cerebral protecting agent, AMG-1, has no effect on delayed neuronal death following ischemia: H. Araki, et al.; Methods Find Exp. Clin. Pharmacol. 11, 731 (1989)
Related Products
| Product Name | Product Code | Supplier | CP-724714 | SYN-1033 | AdipoGen Life Sciences | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ-38877605 | SYN-1047 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AMG-51 | SYN-1111 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AMG-458 | SYN-1144 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MK-2461 | SYN-1149 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||